ACTRN12609000250235已完成4 期
Calcium citrate and its effects on bone loss and hyperparathyroidism in renal transplant recipients
Dr Patrick T Coates0 个研究点目标入组 35 人开始时间: 2009年5月12日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- All
入选标准
- •Previous renal transplant over 1 year ago.
- •Stable renal function (Creatinine < 150) Standard immunosuppression regime (Tacrolimus, Mycophenolate Mofetil and Prednisolone).
- •Able to give informed consent.
- •Able to attend 3 sessions held over 1 week.
排除标准
- •Preexisting hypercalcemia (Ca > 2.55 mmol/L), severe hyperparathyroidism (PTH > 50 pmol/L) or severe vitamin D insufficiency (serum 25-hydoxy vitamin D < 15 ng/mL).
- •Previous parathyroidectomy.
- •Concurrent use of bisphosphonates, Vitamin D analogues, lithium, phenytoin, carbamazepine, hormone replacement therapy, thiazide diuretics.
- •Participation in a concurrent study.
- •Pre-menopausal women (due to low level radiation exposure).
研究者
相似试验
已完成
不适用
Effects of calcium supplementation on bone mineral density in milk allergy childreJPRN-UMIN000024182ational Hospital Organization Kumamoto Medical Center30
招募中
不适用
Effects of etelcalcetide and cinacalcet on bone mineral density in patients with secondary hyperparathyroidismPatients on hemodialysis complicated with secondary hyperparathyroidismJPRN-UMIN000027453Matsunami general hospital30
已完成
不适用
Citrate Effects and Bone Density in Long-Term Apheresis DonorsHealthy Apheresis DonorsNCT00073060National Institutes of Health Clinical Center (CC)273
已完成
不适用
Potassium Citrate to Prevent Age Related Bone LossOsteoporosisNCT00282126University of California, San Francisco52
招募中
不适用
Changes in bone mineral density and serum calcium levels after romosozumab treatmet in postmenopausal osteoporosis patients:About short-term results at 6 monthsJPRN-jRCT1040190111Kobayakawa Tomonori60